Current clinical practice permits the use of single chamber ventricular or
dual chamber pacemakers. However, it is not known which type of pacemaker r
esults in superior clinical and patient outcomes. This is of growing import
ance because of the higher costs and increased risk of technical failures o
f dual chamber pacemakers. Patient outcomes can be assessed with quality of
life questionnaires, but if is unclear which questionnaires are valid for
use in pacemaker patients. This article reappraises studies on quality of l
ife instruments for pacemaker patients. We searched MEDLINE (1985-1998) for
studies assessing quality-of-life in general and in pacemaker patients. Th
e SF-36 appeared to be the best among generic questionnaires because of its
psychometric characteristics and experience of use. Concerning disease spe
cific instruments, the Karolinska qualify of life questionnaire has desirab
le content validity but lacks more rigorous psychometric validation, which
constitutes a serious limitation. Previous studies suggested that implantat
ion of atrioventricular pacemakers improves quality-of-life compared to ven
tricular pacemakers, but since no well-designed and validated questionnaire
exists, these results should be interpreted with caution. The best outcome
measure to evaluate quality-of-life in pacemaker patients would be a combi
nation of a generic health profile with established reliability and validit
y supplemented with a cardiovascular assessment adjusted to suit pacemaker
patients. By doing so, individual scores can be compared within a disease c
ohort and to same-aged, nondiseased persons, as well as other diseased popu
lations. The development and validation of such an instrument is currently
needed.